|
AllergyFight is developing an innovative drug for the prevention and therapy of allergic diseases. The technology is based on the scientific work of Prof. Israel Pecht from the Weizmann Institute and Prof. Anna Erdei.
Read more >>
|
|
Andromeda Biotech Ltd., fully owned by Clal Biotechnology Industries, is focused on development of innovative treatment for autoimmune diabetes.
Read more >>
|
|
BioGAL is a market-driven developer of drug applications for cancer.
Read more >>
|
|
BiondVax Pharmaceuticals Ltd. is developing innovative peptide based vaccines conceptualized and invented by Prof. Ruth Arnon at the Weizmann Institute, Israel. The first application is a universal multi-season/multi-strain influenza vaccine that provides long-term protection against a vast majority of flu viruses.
Read more >>
|
|
BioVent was founded on February 2006, in order to develop novel molecules for the treatment of human and avian influenza infections. BioVent technology is based on a research of the world renowned scientist Prof. Ruth Arnon. The research was published in the Journal of Biological Chemistry (Vol. 279 (2004), No. 46, pp. 48410–48419).
Read more >>
|
|